These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22253088)

  • 21. Preclinical Evaluation of a Fluorine-18 (
    Altine B; Gai Y; Han N; Jiang Y; Ji H; Fang H; Niyonkuru A; Bakari KH; Rajab Arnous MM; Liu Q; Zhang Y; Lan X
    Mol Pharm; 2019 Nov; 16(11):4563-4571. PubMed ID: 31553879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
    Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
    Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
    Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
    Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.
    Lodi A; Woods SM; Ronen SM
    NMR Biomed; 2014 Jun; 27(6):700-8. PubMed ID: 24706368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.
    Elrod HA; Lin YD; Yue P; Wang X; Lonial S; Khuri FR; Sun SY
    Mol Cancer Ther; 2007 Jul; 6(7):2029-38. PubMed ID: 17604333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
    Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
    Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
    Ross J; Najjar AM; Sankaranarayanapillai M; Tong WP; Kaluarachchi K; Ronen SM
    Mol Cancer Ther; 2008 Aug; 7(8):2556-65. PubMed ID: 18723500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.
    Ward CS; Venkatesh HS; Chaumeil MM; Brandes AH; Vancriekinge M; Dafni H; Sukumar S; Nelson SJ; Vigneron DB; Kurhanewicz J; James CD; Haas-Kogan DA; Ronen SM
    Cancer Res; 2010 Feb; 70(4):1296-305. PubMed ID: 20145128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular ATP promotes breast cancer chemoresistance via HIF-1α signaling.
    Yang H; Geng YH; Wang P; Zhang HQ; Fang WG; Tian XX
    Cell Death Dis; 2022 Mar; 13(3):199. PubMed ID: 35236823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling.
    Clem BF; Clem AL; Yalcin A; Goswami U; Arumugam S; Telang S; Trent JO; Chesney J
    Oncogene; 2011 Jul; 30(30):3370-80. PubMed ID: 21423211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds.
    Lucas A; Kim Y; Rivera-Pabon O; Chae S; Kim DH; Kim B
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
    Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
    Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
    Zhou J; Schmid T; Frank R; Brüne B
    J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.
    Shi YH; Wang YX; Bingle L; Gong LH; Heng WJ; Li Y; Fang WG
    J Pathol; 2005 Mar; 205(4):530-6. PubMed ID: 15714461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
    Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
    J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.